1 HNMR (300 MHz, DMSO- d 6 , ppm): H 11.52 (s, 1H, hydrazine-N H ), 9.73 (s, 1H, 4-hydroxy-3,5-dimethoxybenzylidene-N=C H ), 8.91 (s, 1H, 4-hydroxy-3-methoxy benzohydrazide-O H ), 8.34 (s, 1H, 4-hydroxy-3,5-dimethoxybenzylidene-O H ), 7.46 (s, 1H, 4-hydroxy-3-methoxybenzohydrazideC 2 H ), 7.44 (s, 1H, 4-hydroxy-3-methoxybenzohydrazideC 6 H ), 6.89 (brs, 2H, 4-hydroxy-3,5-dimethoxybenzylidene C 2 , 6 H ), 6.87 (brs, 1H, 4-hydroxy-3-methoxybenzohydrazideC 5 H ), 3.85 (s, 3H, 4-hydroxy-3-methoxy benzohydrazide-OC H 3 ), 3.82 (s, 6H, 4-hydroxy-3,5-dimethoxybenzylidene-2(OC H 3 ))
For example, ApoC-II activates lipoprotein lipase, which is responsible for breaking down triglycerides in circulating lipoproteins, releasing fatty acids for energy or storage
This process requires the sequential action of two ATP-dependent enzymes: glutamatecysteine ligase (GCL is composed of two subunits: a catalytic GCLC and a modifier GCLM) and glutathione synthetase (GS)
Since most peptides are administered via subcutaneous injection, mild injection site irritation may occur
Study: Subcutaneous Semaglutide during Breastfeeding: Infant Safety Regarding Drug Transfer into Human Milk